Related Experiment Video
Updated: May 24, 2026

Live-imaging of PKC Translocation in Sf9 Cells and in Aplysia Sensory Neurons
Published on: April 6, 2011
Synergistic effect of PKC activation and actin filament disruption on carbonate apatite-facilitated lymphocyte
K Fukuda1, K Kutsuzawa, K Maruyama
1Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Japan.
Abstract:
Leukemia and lymphoma cells are potential targets for genetic manipulation in cancer therapy. On the other hand, genetically modified autologous lymphocytes expressing a chimeric antigen against a receptor overexpressed in tumor cells or tumor vasculature are promising cell-based therapeutics for cancer.However, the lack of a smart device for efficient transgene delivery to the lymphocytes poses the major obstacle to the successful clinical applications of these attractive approaches. Recently, we developed a carbonate apatite-based nanocarrier system for effective intracellular delivery and release of DNA molecules, achieving very high level of transgene expression in both primary and cancer cells. Although its efficacy in human T leukemia cells is relatively poor, immobilization of fibronectin and/or chimeric E-cadherin-Fc on particle surface could enhance transgene delivery in presence of an actin filament disrupter. Here, we report for the first time that simultaneous stimulation of human T leukemia cells by a protein kinase C (PKC) activator, a Ca(2+) ionophore and an actin filament disrupter dramatically accelerated carbonate apatite-mediated transgene delivery in the cells, resulting in over 100-fold more efficacy than commcercially available lipofectamine.
Insights
Researchers enhanced gene delivery to leukemia cells using a novel nanocarrier. Simultaneous stimulation with specific agents dramatically improved transgene expression, offering a promising cancer therapy tool.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Research
Background:
- Leukemia and lymphoma cells are targets for genetic manipulation in cancer therapy.
- Genetically modified lymphocytes show promise as cell-based cancer therapeutics.
- Efficient transgene delivery to lymphocytes is a major obstacle for clinical applications.
Purpose of the Study:
- To develop an efficient method for transgene delivery to human T leukemia cells.
- To improve the efficacy of carbonate apatite-based nanocarriers for gene therapy.
Main Methods:
- Developed a carbonate apatite-based nanocarrier system for DNA delivery.
- Investigated the enhancement of transgene delivery using fibronectin and/or chimeric E-cadherin-Fc.
- Stimulated human T leukemia cells with a protein kinase C (PKC) activator, a Ca(2+) ionophore, and an actin filament disrupter.
Main Results:
- The nanocarrier system achieved high transgene expression in primary and cancer cells.
- Simultaneous stimulation dramatically accelerated carbonate apatite-mediated transgene delivery in human T leukemia cells.
- Achieved over 100-fold greater efficacy compared to commercially available lipofectamine.
Conclusions:
- Simultaneous stimulation significantly enhances carbonate apatite-mediated gene delivery to human T leukemia cells.
- This approach represents a breakthrough for cell-based cancer therapeutics.
- Offers a superior alternative to existing gene delivery methods for leukemia treatment.
Related Concept Videos
Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Intracellular Signaling Affects Focal Adhesions
Some...
cAMP-dependent Protein Kinase Pathways
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Anaphase Promoting Complex

